Contact: Jules Asher
NIH/National Institute of Mental Health
Caption: Little beta-amyloid can be seen in microglia of a mouse line in which CD33 is over-expressed (C"), compared to microglia of mice in which CD33 is experimentally inactivated (D"). Evidence from post-mortem human brains indicates that CD33 is similarly over-active in Alzheimer's disease, suggesting that a treatment that impedes it might help treat or prevent the disease.
Credit: Rudolph Tanzi, Ph.D., of Massachusetts General Hospital and Harvard University
Usage Restrictions: None
Related news release: Suppressing protein may stem Alzheimer's disease process